"10.1371_journal.pone.0018559","plos one","2011-04-11T00:00:00Z","Selidji T Agnandji; Rolf Fendel; Michaël Mestré; Michel Janssens; Johan Vekemans; Jana Held; Ferdinand Gnansounou; Sonja Haertle; Isabel von Glasenapp; Sunny Oyakhirome; Ludovic Mewono; Philippe Moris; Marc Lievens; Marie-Ange Demoitie; Patrice M Dubois; Tonya Villafana; Erik Jongert; Aurelie Olivier; Joe Cohen; Meral Esen; Peter G Kremsner; Bertrand Lell; Benjamin Mordmüller","Medical Research Unit, Albert Schweitzer Hospital, Lambaréné, Gabon; Institut für Tropenmedizin, Universität Tübingen, Tübingen, Germany; GlaxoSmithKline Biologicals, Wavre, Belgium; ImmunoVacc Consulting, Brussels, Belgium; PATH Malaria Vaccine Initiative, Bethesda, Maryland, United States of America","Conceived and designed the experiments: JV PM MAD PD TV JC PGK BL BM. Performed the experiments: STA RF MM MJ JH FG SH IvG SO LM TV PGK BL. Analyzed the data: STA RF JV ML PD EJ JC PGK BL BM. Contributed reagents/materials/analysis tools: STA JH SH IvG SO MAD EJ ME BM. Wrote the paper: STA JV PD ML AO PGK BL BM.","JV, MM, MJ, PM, ML, M-AD, PD, EJ, AO, JC are employees of GSK Biologicals. JC owns shares in GSK and is listed as an inventor of patented malaria vaccines, but does not hold a patent for a malaria vaccine. PD is an employee of ImmunoVacc Consulting. There are no conflicts of interest for other authors. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2011","04","Selidji T Agnandji","STA",23,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
